We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
-1.95%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+1,200.89%
AUM
$644M
AUM Growth
-$11.6M
Cap. Flow
+$4.95M
Cap. Flow %
0.77%
Top 10 Hldgs %
29.5%
Holding
191
New
14
Increased
56
Reduced
81
Closed
12

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$17.8M
2
ALB icon
Albemarle
ALB
+$6.7M
3
AAPL icon
Apple
AAPL
+$3.35M
4
LYB icon
LyondellBasell Industries
LYB
+$2.4M
5
IBM icon
IBM
IBM
+$1.21M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.77M
2
JNJ icon
Johnson & Johnson
JNJ
+$2.95M
3
WFC icon
Wells Fargo
WFC
+$2.69M
4
POT
Potash Corp Of Saskatchewan
POT
+$1.96M
5
DUK icon
Duke Energy
DUK
+$1.95M

Sector Composition

Rank Sector Weight
1 Healthcare 20.98%
2 Technology 20.17%
3 Financials 12.36%
4 Industrials 9.1%
5 Consumer Staples 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
151
Visa
V
$671B
$382K 0.06%
3,192
– –
FDX icon
152
FedEx
FDX
$77.3B
$378K 0.06%
1,572
+407
+35% +$103K
AABA
153
DELISTED
Altaba Inc
AABA
$370K 0.06%
5,000
-1,000
-17% -$75.4K
AKAM icon
154
Akamai
AKAM
$17.6B
$362K 0.06%
5,100
-4,600
-47% -$313K
COLL icon
155
Collegium Pharmaceutical
COLL
$834M
$358K 0.06%
+14,000
New +$334K
CUZ icon
156
Cousins Properties
CUZ
$4.85B
$347K 0.05%
10,002
– –
FIS icon
157
Fidelity National Information Services
FIS
$21.6B
$340K 0.05%
+3,530
New +$346K
IBB icon
158
iShares Biotechnology ETF
IBB
$9.86B
$325K 0.05%
3,045
-300
-9% -$33.3K
UVE icon
159
Universal Insurance Holdings
UVE
$1.18B
$319K 0.05%
10,000
– –
NEE icon
160
NextEra Energy
NEE
$179B
$280K 0.04%
6,848
– –
DXCM icon
161
DexCom
DXCM
$34.3B
$260K 0.04%
14,000
– –
BXMX
162
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$250K 0.04%
18,766
– –
MDLZ icon
163
Mondelez International
MDLZ
$79.4B
$244K 0.04%
5,855
-85
-1% -$3.69K
NFLX icon
164
Netflix
NFLX
$309B
$242K 0.04%
+8,200
New +$223K
FITB
165
Fifth Third Bancorp
FITB
$52.6B
$238K 0.04%
7,500
– –
DLPH
166
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$238K 0.04%
4,989
-2,877
-37% -$149K
BR icon
167
Broadridge
BR
$19.3B
$229K 0.04%
2,089
-200
-9% -$19.9K
IVV icon
168
iShares Core S&P 500 ETF
IVV
$904B
$214K 0.03%
805
– –
IAT icon
169
iShares US Regional Banks ETF
IAT
$687M
$207K 0.03%
+4,104
New +$214K
NEOG icon
170
Neogen
NEOG
$2.5B
$201K 0.03%
+6,000
New +$181K
KERX
171
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$198K 0.03%
48,350
-2,000
-4% -$9.31K
F icon
172
Ford
F
$55.1B
$171K 0.03%
15,430
-900
-6% -$10.2K
CDXS icon
173
Codexis
CDXS
$172M
$132K 0.02%
+12,000
New +$115K
MDXG icon
174
MiMedx Group
MDXG
$624M
$84K 0.01%
12,000
-7,000
-37% -$81.5K
UAN icon
175
CVR Partners
UAN
$1.26B
$76K 0.01%
+2,353
New +$82.5K
4 5 6
7
8

Similar funds

KCM
Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return
ACL
Azora Capital LP Miami, Florida $1.52B AUM 39.16% 1-Year Est. Return
ARAM
Ardmore Road Asset Management New York $1.52B AUM 56.21% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Marco Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Marco Investment Management held 191 positions worth $644M, down 1.8% from $656M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Marco Investment Management's Q1 2018 filing shows 14 new, 56 increased, 81 reduced and 12 closed positions. Its largest new stake was Albemarle: 60,800 shares worth $5.64M. The largest sale was AbbVie, an estimated $4.77M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Marco Investment Management's largest Q1 2018 buy was Albemarle: 60,800 shares worth $5.64M.
  • Marco Investment Management added most to Allergan plc in Q1 2018, an estimated $17.8M increase.
  • Marco Investment Management's biggest Q1 2018 reduction was AbbVie, cutting an estimated $4.77M.
  • Marco Investment Management fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $1.96M.
  • Marco Investment Management's ten largest holdings make up 30% of its $644M portfolio in Q1 2018.
  • Marco Investment Management opened 14 new positions and closed 12 in Q1 2018.
  • Marco Investment Management's portfolio value fell 1.8% quarter-over-quarter to $644M.

Based on Marco Investment Management's 13F filing for Q1 2018, filed 1 May 2018.